DeCell Technologies
Latest round
- Seed
Last raised
- Nov 2013
Total raised
- $0.3M
Investors
- 1
About DeCell Technologies
DeCell Technologies Inc.DeCell Technologies Inc. focuses on developing innovative wound care products. The company is headquartered in Halifax, Canada.DeCell Technologies specializes in advanced wound care solutions, primarily through its flagship product, DermGEN™, a patented human dermal matrix designed for the treatment of difficult-to-heal wounds. DermGEN™ ensures the highest level of donor cell removal, minimizing the risk of foreign immune responses and facilitating tissue acceptance and healing. The product maintains the natural composition and structure of tissue, stimulating regenerative cell responses essential for wound recovery. It is pre-hydrated and ready to use, allowing for easy application without the need for sutures or staples.DeCell Technologies generates revenue primarily through the direct sales of its DermGEN™ product to healthcare institutions. The company operates on a transactional model where healthcare providers place orders for DermGEN™ units based on their patient needs and specific cases of difficult-to-heal wounds. Each application of DermGEN™ is designed for a single use in patient care, promoting repeat purchases as healthcare facilities restock their supplies. The pricing structure reflects the advanced technology and clinical efficacy associated with DermGEN™, positioning it as a premium offering in the wound care market.DeCell Technologies aims to expand its product line, focusing on upcoming innovations in wound care solutions. The company is targeting growth in North America and Europe, planning to launch new products by the end of 2024. Additionally, DeCell was acquired by AirSage in March 2015, indicating a strategic shift in operations that may bolster its market presence.
Who invested in DeCell Technologies
1 investor across 1 round
See all investors in DeCell Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 13, 2013
Amount
$0.3M
Investors
Questions about DeCell Technologies
Who invested in DeCell Technologies?
DeCell Technologies has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has DeCell Technologies raised?
DeCell Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did DeCell Technologies last raise money?
DeCell Technologies's most recent round on record is a Seed, in Nov 2013.
What does DeCell Technologies do?
DeCell Technologies is a medical devices & equipment company.
Where is DeCell Technologies headquartered?
DeCell Technologies is headquartered in Halifax, Canada.
Which VCs invest in companies like DeCell Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at DeCell Technologies's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like DeCell Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.